These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Study of the changes in collagen of the tunica albuginea in venogenic impotence and Peyronie's disease. Chiang PH; Chiang CP; Shen MR; Huang CH; Wang CJ; Huang IY; Shieh TY Eur Urol; 1992; 21(1):48-51. PubMed ID: 1606983 [TBL] [Abstract][Full Text] [Related]
6. Patients with Dupuytren's Contracture, Ledderhose Disease, and Peyronie's Disease are at higher risk of arthrofibrosis following total knee arthroplasty. Wang CX; Flick TR; Patel AH; Sanchez F; Sherman WF Knee; 2021 Mar; 29():190-200. PubMed ID: 33640618 [TBL] [Abstract][Full Text] [Related]
7. [A COLLAGEN TRIAD: LA PEYRONIE'S DISEASE, DUPUYTREN'S DISEASE AND FIBROSIS OF THE AURICULAR CARTILAGE]. GALLIZIA F J Urol Nephrol (Paris); 1964 Jun; 70():424-7. PubMed ID: 14171347 [No Abstract] [Full Text] [Related]
8. Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes. Gelbard MK; Rosenbloom J Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00195. PubMed ID: 33855203 [TBL] [Abstract][Full Text] [Related]
9. Proposal: trauma as the cause of the Peyronie's lesion. Devine CJ; Somers KD; Jordan SG; Schlossberg SM J Urol; 1997 Jan; 157(1):285-90. PubMed ID: 8976281 [TBL] [Abstract][Full Text] [Related]
10. Peyronie's disease and Dupuytren's contracture secondary to topical timolol. Oliphant H; Gouws P Int Ophthalmol; 2019 Mar; 39(3):683-685. PubMed ID: 29423783 [TBL] [Abstract][Full Text] [Related]
11. Tocopherols in treatment of primary fibrositis; including Dupuytren's contracture, periarthritis of the shoulders, and Peyronie's disease. STEINBERG CL AMA Arch Surg; 1951 Dec; 63(6):824-33. PubMed ID: 14868250 [No Abstract] [Full Text] [Related]
12. Peyronie's disease: a newly recognized autosomal-dominant trait. Bias WB; Nyberg LM; Hochberg MC; Walsh PC Am J Med Genet; 1982 Jun; 12(2):227-35. PubMed ID: 6213155 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory mechanisms and oxidative stress in Peyronie's disease: therapeutic "rationale" and related emerging treatment strategies. Paulis G; Brancato T Inflamm Allergy Drug Targets; 2012 Feb; 11(1):48-57. PubMed ID: 22309083 [TBL] [Abstract][Full Text] [Related]
15. A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie's disease. Patel DP; Christensen MB; Hotaling JM; Pastuszak AW World J Urol; 2020 Feb; 38(2):253-261. PubMed ID: 31190155 [TBL] [Abstract][Full Text] [Related]
16. Is colchicine effective in Peyronie's disease? A pilot study. Akkus E; Carrier S; Rehman J; Breza J; Kadioglu A; Lue TF Urology; 1994 Aug; 44(2):291-5. PubMed ID: 8048212 [TBL] [Abstract][Full Text] [Related]
18. Development of Peyronie's and Dupuytren's diseases in an individual after single episodes of trauma: a case report and review of the literature. Connelly TJ J Am Acad Dermatol; 1999 Jul; 41(1):106-8. PubMed ID: 10411420 [TBL] [Abstract][Full Text] [Related]